exo-is/governance-reporting-on-listed-companies huggingface dataset:
Keyword: governance
Late-Stage Pipeline & Marketed Product Governance
for driving our pipeline of innovation and achieving better
team – assess the product throughout its lifecycle to
patient outcomes. We focus our investments in precision
ensure it is scientifically and commercially sound. These
medicine, genetics and genomics, data convergence,
governance bodies are also tasked with identifying trends
patient-focused drug development and advanced
and potential risks, determining funding and making
technologies, often using strategic partnerships with
recommendations throughout the asset’s lifecycle.
other companies and research institutions to amplify and
accelerate the impact of our innovations. • When a product is developed alongside a partner, pipeline
decisions and recommendations are made by the Joint
Keyword: governance
organizations, caregivers and clinicians to ensure thatOur Approach to ESG Environmental Social Governance 30
2023 ESG Action Report
Our Core Therapeutic Areas
Immunology Oncology Neuroscience
We work to help people living with chronic, Our goal is to transform the way cancer To raise the standards of care for
progressive diseases in rheumatology, is treated. Our scientific discoveries have neurological diseases and psychiatric
dermatology and gastroenterology live already changed the treatment of blood disorders, we are exploring innovative,
full lives without limits from their disease. cancer, and now we are working to discover disease-modifying solutions to address
therapies that deliver better, longer-lasting areas of unmet need, including Parkinson’s,
results for patients with solid tumors. Alzheimer’s, schizophrenia, migraine, stroke,
dep
Keyword: governance
Read more online Read more online Read more onlineOur Approach to ESG Environmental Social Governance 31
2023 ESG Action Report
Innovating for Patients
To help solve serious health issues today and address
the medical challenges of tomorrow, we continuously
The Role of AI in Research in less time. The first-of-its-kind platform,
evolve and enhance our product portfolio. In our
which won a Bio-IT World Innovative Practices
and Development
drive to discover and develop novel medicines and
award in 2023, gives our research teams better
treatments, we have invested $7.8 billion in adjusted At AbbVie, we believe in the responsible
access to integrated information and advanced
R&D¹ and received seven major product or indication use of artificial intelligence (AI) to enhance
analytics, ranging from safety data to molecular
approvals in 2023. phar
Keyword: governance
² Compounds, devices or indications in development individually or under collaboration or license agreementsOur Approach to ESG Environmental Social Governance 32
2023 ESG Action Report
Applications and Approvals
In 2023, we received several therapeutic product indication Pathway to Cures
approvals from the FDA, the EMA, Japan’s Pharmaceuticals
Lake County, Illinois
In 2021, AbbVie launched R&D Pathway to Cures, a bold
and Medical Devices Agency (PMDA), and other regional
initiative that aims to deliver more potential cures for
and national agencies:
our patients. Underscoring the importance of cross-
• QULIPTATM functional collaboration and innovation, R&D Pathway to
For the preventative treatment of chronic migraine in Cures strives to advance our pipeline and enhance our
adults (U.S. and EU) capabilities for discovering, developing and delivering
novel medicines with curative potential.
• EPKI
Keyword: governance
further details of our pipeline of investigational medicines.Our Approach to ESG Environmental Social Governance 33
2023 ESG Action Report
Partnering for Greater Our corporate venture capital arm, AbbVie Ventures, focuses its
investments exclusively on novel, transformational therapeutics
Lake County, Illinois
Impact
at discovery and preclinical stages to address critical needs in
oncology, immunology, neuroscience, eye care and aesthetics.
We recognize the power of collaborating with strategic
Gaining access to next-generation science and building
partners to amplify the impact of our innovations. We
relationships with proven and emerging scientific leaders,
partner with small biotech companies, universities and
our current portfolio is made up of more than 20 companies based
other pharmaceutical companies around the world to
in the United States an
Keyword: governance
58 million people worldwide.Our Approach to ESG Environmental Social Governance 34
2023 ESG Action Report
2023 Acquisitions
The Innovative Health Initiative In 2023, the IMI and IHI projects where we have made
In November 2023, we announced an agreement to
substantial patient-focused contributions include:
acquire ImmunoGen and its flagship ovarian cancer
The Innovative Health Initiative (IHI) is the world’s
therapy ELAHERE®. The transaction, completed in
largest public–private partnership in health care. It is a
• Harmony
February 2024, will accelerate our presence in the solid
collaboration between the EU and the pharmaceutical,
We contributed to major achievements such as the
tumor space.
biotechnology, digital health and medical technology
definition of core outcome measures in hematologic
sectors, along with acad
Keyword: governance
Worcester, MassachusettsOur Approach to ESG Environmental Social Governance 35
2023 ESG Action Report
Conducting Clinical Trials functional team in the development risk management, site
monitoring and central monitoring plans. The study team
Clinical trials are a critical component to delivering life-
also identifies and reports risk indicators to the Central
changing medicines, and we are committed to maintaining
Monitor for inclusion in the central monitoring plan before
the highest standards and protecting patients throughout
potential participants are screened.
the process. AbbVie’s vision is to be the industry leader
Throughout the study, the Study Risk Lead facilitates
in designing inclusive clinical research programs through
a risk management meeting with the extended cross-
unparalleled partnerships with d
Keyword: governance
¹ International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human UseOur Approach to ESG Environmental Social Governance 36
2023 ESG Action Report
Patient Centricity Pre-Approval Access Programs
Our pre-approval access programs span a range of
Digital Innovation in Measuring We always require explicit informed consent from
medicines across oncology, immunology, neuroscience and
individuals before they can join an AbbVie-sponsored
Clinical Efficacy
other therapeutic areas. These are determined on a case-by-
clinical trial, unless waived by a country-level Institutional
In the dynamic landscape of health care, digital case basis and subject to established regulatory pathways.
Review Board (IRB), Independent Ethics Committee (IEC) or
innovation is revolutionizing how we assess
equivalent entity. In countries where written authorization
While we cannot predict e
Keyword: governance
our Commitment to Trial Participants.Our Approach to ESG Environmental Social Governance 37
2023 ESG Action Report
The AbbVie Research Collaborative The Collaborative enables our world-class scientific
Irvine , California
researchers to analyze real-world health data, uncovering
A transformative initiative where patients actively
trends and insights that may remain hidden in historical
shape the future of health care by sharing their insights
data or a traditional clinical trial. Through this process,
and data to impact research, the AbbVie Research
we not only gain a better understanding of various
Collaborative welcomes individuals from all walks of
conditions but also identify potential eligible candidates
life and medical experience.1 We value diversity as it
for our own clinical trials and observational studies,
enriches
Keyword: governance
¹ Participants must be at least 18 years old and living in the United States.Our Approach to ESG Environmental Social Governance 38
2023 ESG Action Report
Clinical Trial Diversity and Inclusion initiative, to educate patients, caregivers, health care
providers and organizations about clinical research. The
Clinical research is a key step in understanding whether
program seeks to destigmatize clinical trials, increase
medications are safe and effective, and ensuring that
the participation and representation of underrepresented
volunteers include people of different races, ethnicities,
groups, and develop resources and partnerships to help
genders and backgrounds. Our enterprise-level approach
advance health equity in three ways:
continues to integrate diverse perspectives into strategic
decisions during the development process to ensure our
• Advocate
solutions are p
Keyword: governance
through Inclusive Representation and Equity (ADMIRE)Our Approach to ESG Environmental Social Governance 39
2023 ESG Action Report
We also ran our first Aesthetics Diversity Summit, which “
brought together physicians from the United States and
I’m so thrilled to be starting this amazing and rewarding journey of clinical
Brazil to advance the next generation of diverse clinical
investigators in aesthetic medicine. research with another training that benefits our patients, practices and
communities with a DEI approach. I’m so lucky to have such a great network
Almost 1,800 inquiries from new sites and investigators
have been received in the last year and are being
of professionals supporting and empowering me every day.”
vetted for future collaboration, training and partnership
opportunities via the ADMIRE program: Dr. Maria Gabriela Eizaga,
O
Keyword: governance
² KPI first introduced for the 2022 ESG Action Report. AbbVie is only reporting data from 2022 onward for this KPI.Our Approach to ESG Environmental Social Governance 40
2023 ESG Action Report
Product Quality and Safety
By implementing and maintaining robust quality controls from end to end, our patients, customers and regulators can rely on us to deliver a
consistent supply of innovative, safe and effective products that solve serious health issues and have a remarkable impact on people’s lives.
Knowing that our transformative medicines and products Since May 2020, when AbbVie acquired Allergan, we have
matter only if they are safe, effective and accessible, we integrated all commercial affiliates and harmonized the
hold ourselves to the highest standards of quality and QS across all manufacturing facilities and completed
safety, aligning our work to our beliefs: the integration of Allergan’s QS into A
Keyword: governance
That requires a robust and effective governance structure,
have nine active ISO 13485 certificates and eight MDSAP
supported by tools, technology and training, to manage the
certifications across our device business.
QS and drive continuous improvement to achieve the highest
quality products to meet patient needs. It also requires a
culture in which everyone in the business, regardless of their
role, is empowered to take responsibility for quality.
Cork, IrelandOur Approach to ESG Environmental Social Governance 41
2023 ESG Action Report
Management Responsibilities Process Performance and Product
Quality (PP&PQ)
Management is accountable for ensuring our
products are fit for intended use and comply with PP&PQ drives the creation and constant monitoring
appropriate regulatory requirement
Keyword: governance
down to forms. Data integrity and data governance risks to the patient and the quality of the product.
are key elements.
We also have controls in place to mitigate counterfeit or Committee of the board of directors are updated on accountable to the CEO. Regarding product-related risks, our
diverted drug risks and allow for the safe disposal of drugs. a regular basis. AbbVie’s Quality Assurance team is Global Anti-Counterfeiting Steering Committee is responsible
responsible for certifying that our QS is compliant for identifying and mitigating risks related to AbbVie
Beyond internal control measures, our quality processes
with all applicable regulations. Therefore, a focus on medicines. In addition, AbbVie’s Product Security Alert Board
are reviewed, certified and audited by multiple exter
Keyword: governance
AbbVie’s CEO, and the Public Policy & Sustainability Senior Quality Leadership from Operations and R&D—isOur Approach to ESG Environmental Social Governance 42
2023 ESG Action Report
Employee Training
Quality Risk Management
Training plays a crucial role in shaping our company
quality culture, and by investing in comprehensive product Quality Risk Management (QRM) is a systematic process
quality and safety training programs, we equip our for the assessment, control, communication and review
employees to excel. of risks to the patient and to the quality of the product
or device across the product lifecycle. The primary
AbbVie Operations utilizes a validated Learning
focus – to protect the patient – is achieved by analyzing
Management System (LMS) to manage all applicable
potential hazards and applying appropriate mitigation.
global standards and regulations for Good Manufacturing
AbbVie takes a
Keyword: governance
Lake County, IllinoisOur Approach to ESG Environmental Social Governance 43
2023 ESG Action Report
Quality Control Quality control at AbbVie relies on a dedicated team Audits
of experts, advanced equipment and effective quality
Quality controls help our products meet the desired In 2023, AbbVie sites and affiliates received 95 inspections
management systems to monitor our consistency with
standards and specifications before they reach our from regulatory authorities and notified bodies around
quality standards. Our facilities must also be free from
patients. This crucial process involves the systematic the world, including two successful FDA pre-approval
contamination. Our Contamination Control team provides
inspection, testing and monitoring of our products inspections. These resulted in approval of alternate
Keyword: governance
maturity through a series of guidance documents.Our Approach to ESG Environmental Social Governance 44
2023 ESG Action Report
Pharmacovigilance, Epidemiology and AbbVie is targeting the theft, counterfeiting and diversion Our transport security program works to combat diversion
of our products across therapeutic areas. The actions we and theft risks across road, air and ocean routes by using
R&D Quality
are taking include enhancing security features on product GPS tracking and geofencing on high-risk, high-value routes,
AbbVie’s Chief Safety Officer is responsible for leading
packaging and labels. In addition, we are collaborating with using approved secure stopping locations and having drivers
AbbVie’s Pharmacovigilance, Patient Safety, Epidemiology
supply chain partners, including government, customs and notify our control towers of di
Keyword: governance
¹ KPI first introduced for the 2022 ESG Action Report. AbbVie is only reporting data from 2022 onward for this KPI.Our Approach to ESG Environmental Social Governance 45
2023 ESG Action Report
Patient Health and Engagement
At AbbVie, we believe patient well-being requires care and guidance at every step along the treatment journey. We recognize that our
products need to be safe, effective and available to everyone who needs them. Our work is about the patient and for the patient, providing
meaningful solutions and working with partners to advance patient health together.
Our Approach
Across AbbVie, our work is guided by patient needs, and
their lived experiences inform not only the breakthroughs we
pursue but also our work to improve their health outcomes
and support them on their healthcare journey. From drug
discovery and development to ensuring our medicines are
accessible and affordable, we include
Keyword: governance
underserved populations.Our Approach to ESG Environmental Social Governance 46
2023 ESG Action Report
The Patient Experience Patient Support Programs Many of the AbbVie Care programs provide patients with
support and information to help them access, understand
We seek to understand the patient’s journey as they Our patient support programs play a crucial role in
and adhere to their AbbVie therapy. This is provided through
navigate the complexities of living with their disease, enhancing the overall treatment experience for individuals
a variety of resources, including:
as well as the point of view of the caregiver, health care prescribed AbbVie medicines across our immunology,
• Support from specialist nurses, either in person or virtually
provider (HCP) and payer. All parts of our organization neuroscience, oncol
Keyword: governance
confidence to use the device correctly in their own homes. Lake County , IllinoisOur Approach to ESG Environmental Social Governance 47
2023 ESG Action Report
Improving Health Literacy
Parkinson’s Patient Support Programs Building on our legacy of DUODOPA® intestinal gel Levels of health literacy vary by region and can be lower
(levodopa/carbidopa), we developed PRODUODOPA® among some populations, including vulnerable groups
At AbbVie, we are transforming Parkinson’s disease to
(foslevodopa/foscarbidopa), the first and only such as the elderly and those with low incomes. This is
deliver better outcomes today and elevate the standard of
subcutaneous 24-hour infusion of levodopa-based why we work hard to ensure that the health information we
care tomorrow. We see it as our responsibility to help the
therapy for advanced Parkinson’s disease. provide to patients is clear, s
Keyword: governance
¹ Known as Nurse Ambassadors in the United StatesOur Approach to ESG Environmental Social Governance 48
2023 ESG Action Report
Engaging With the Patient The patient advocacy community enables us to garner
diverse perspectives and build a greater understanding
Advocacy Community
of the unique experiences and challenges of the patient
journey from diagnosis to navigating complex health
We partner with patient advocacy groups and value
systems. This helps inform our decisions from drug
the insights they share on the patient and caregiver
development to packaging design and delivery. Through
experience. Across functions at AbbVie, we foster
these partnerships, we also support patient and caregiver
relationships with such groups based on mutual trust,
education specific to disease states and share information
respect, transparency, and shared
Keyword: governance
Chicago, IllinoisOur Approach to ESG Environmental Social Governance 49
2023 ESG Action Report
Independent Education
Grants
Our independent education grants support scientific and
medical education programs that aim to address critical
education gaps across our priority disease areas, to improve
patient outcomes, advance health equity and improve health
literacy. We support continuing medical education programs
that offer unbiased education for HCPs and scientists
on current, new and emerging science. Our grants also
fund fellowships that increase capacity and knowledge in
under-resourced fields and educate providers on medical
advances and emerging therapies. In addition, we are
committed to addressing disparities through funding for
fellowships and internships directed at underrepresented
minority medical
Keyword: governance
application process, can be found on our website.Our Approach to ESG Environmental Social Governance 50
2023 ESG Action Report
Patient Access and Affordability
We recognize that our innovative treatments can only make a difference if they are Our Approach
available and accessible to patients. Therefore, innovation needs to work in harmony with
To help address the world’s toughest health challenges, our
pricing and access so that the patients who need our medicines can benefit from them.
approach to pricing and affordability aims to drive broad
and rapid access to our medicines. We price our medicines
to reflect the value they bring to patients and their families,
health care providers, governments and other stakeholders,
as well as the long-term sustainability of our innovation and
societal impact.
Innovative treatments are most impactful
Keyword: governance
health outcomes.Our Approach to ESG Environmental Social Governance 51
2023 ESG Action Report
Initiatives to Enhance In addition, AbbVie makes direct donations to independent procurement agencies may easily find patent holders and
Charitable Patient Assistance Programs across several communicate directly with companies selling the medicines
Equitable Access
disease funds. These foundations offer co-pay assistance they need.
for U.S. patients in need, regardless of whether their
AbbVie offers a range of programs to help patients In addition, to support access to medicines for those in need
treatment involves AbbVie medicines. They also provide
access the medicines they need. Each program is tailored with no means of accessing them due to limitations and
assistance to patients for insurance premiums and othe
Keyword: governance
218,000 U.S. patients.Our Approach to ESG Environmental Social Governance 52
2023 ESG Action Report
To assist with out-of-pocket cost of medicines, AbbVie AbbVie provides access to investigational drugs prior to
offers several programs that help to reduce the cost regulatory approval for patients who suffer from serious
Fighting Visual Impairment in Africa
burden for patients to pay for our medicines. Each program or life-threatening illness, as determined on a case-by-
The state of eye care in Africa stands in alarming contrast
is tailored to meet the unique needs of patients and case basis and implemented through programs subject to
to that of the rest of the world. According to the WHO,
the patient communities within the specific geography, established regulatory pathways. Our compassionate use
approximately
Keyword: governance
Saharan regions.Our Approach to ESG Environmental Social Governance 53
2023 ESG Action Report
Advancing Health External Partnerships to Drive Patient-
Centered Research
Economics and Outcomes
Several external partnerships were established in 2023
Research to enhance and drive the integration of the patient voice
throughout our medical product development programs.
Health Economics and Outcomes Research (HEOR) designs
and executes research to understand the patient experience • HEOR launched the Lung Cancer Health Outcomes
and identify the outcomes that matter most to patients for Research Advisory Committee, with global experts in
novel endpoint development in both randomized controlled oncology and pathology providing valuable insights on
trials (RCTs) and real-world research. Furthermore, HEOR patient-re
Keyword: governance
physicians to support disease management decisions.Our Approach to ESG Environmental Social Governance 54
2023 ESG Action Report
2023 U.S. Highlights in Patient-Centric Outcomes
Real-World Evidence to Improve Migraine
Patient Outcomes Among Employees
Following implementation of AbbVie’s Migraine at
Work™ program in 2022, a 12-week initiative designed
to raise awareness about migraines among U.S.
employees, the ENLiGHTEN study was conducted in
2023 to evaluate the impact of the program on migraine
LINZESS® for FC RINVOQTM for CD and UC QULIPTATM for migraine
management and work productivity.
Patient-reported outcome (PRO) RINVOQ was approved by the FDA Following an initial approval in
The study showed positive results on the impact of the
endpoints supported the FDA as the first and only oral treatment episodic migraine, QULIPTA was
migraine
Keyword: governance
² As defined by the World Bank, including low income, lower middle income and upper middle income countries.Our Approach to ESG Environmental Social Governance 55
2023 ESG Action Report
Human Capital Management
We take a holistic approach to managing our people, emphasizing professional and
leadership development, employee well-being and a culture that unleashes the full potential
of our team. At AbbVie, every one of our approximately 50,000 employees helps shape and
define our path forward, to make a real difference in people’s lives.
Our Approach
Decisions related to human capital management are made
Attracting, recruiting and retaining the best talent and by our executive leadership and amplified at functional
enhancing strategic and leadership capabilities through levels. Additional councils and committees also govern
meaningful learning and development opportunities key functions, such as th
Keyword: governance
Lake County, IllinoisOur Approach to ESG Environmental Social Governance 56
2023 ESG Action Report
Our Culture Attracting Talent
Our proactive approach to attracting, engaging and hiring
Our workplace culture is built upon three fundamental guideposts:
people governs our talent strategy and is applied across
all stages of the recruitment pipeline, from early career to
executive leadership.
Our multi-year roadmap for talent acquisition and workforce
Our Principles The Ways We Work Talent Philosophy
planning ensures that we maintain a rigorous, efficient and
inclusive process. This involves having a strong operating
Represent who we are and what we Encompass how we break through. Prioritize what AbbVie does to model, optimized processes and technology, excellence
stand for: transforming lives, acting They are a s
Keyword: governance
and Hispanic Alliance for Career Enhancement.Our Approach to ESG Environmental Social Governance 57
2023 ESG Action Report
Broad-Based Development Solutions AbbVie 360 is available to all employees and provides
Learning and Leadership
specific developmental feedback to employees on how
Across the business, we offer a wide array of leadership
Development they are demonstrating our leadership attributes. It helps
development programs. In 2023, we hosted workshops
the learner understand their strengths and opportunities for
and webinars on a variety of development topics, including
We believe development is critical to our business
improvement. Also, AbbVie provides customized leadership
talent and performance management, as well as new people
performance and the engagement of our employees, but
assessments, coaching and training to acce
Keyword: governance
Lake County , IllinoisOur Approach to ESG Environmental Social Governance 58
2023 ESG Action Report
Advancing Our Culture:
Washington, D.C.
Employee Engagement
AbbVie is recognized as a top employer based on positive
92%
employee feedback, competitive benefits and development
opportunities, among other robust offerings. Measuring
Overall employee survey response rate
our impact is the first step in continuous improvement.
Our global Employee Survey, conducted every two years,
is designed specifically to gather feedback from across
Percentage of AbbVie employees who:
multiple dimensions of the employee experience, such as
culture, trust, work-life integration, well-being, development are engaged – believe that feel good about
and innovation. having energy AbbVie is building the ways AbbVie
and commitment the cult
Keyword: governance
Great Place to Work®, which conduct independent surveys.Our Approach to ESG Environmental Social Governance 59
2023 ESG Action Report
Equity, Equality, Diversity Key Performance Indicators: 2021 2022 2023
Talent Attraction, Retention and Development
and Inclusion
Overall Turnover Rate 11% 10% 9%
Developing and bringing innovative, life-changing medicines
to patients requires diversity of thought, which comes from
Voluntary Turnover Rate 8% 8% 6%
a diverse workplace. We serve a wide variety of patient
populations worldwide and it is essential that we strive to
New Hires 8,000 7,500 6,100
reflect their diversity and represent their voices. Our EEDI
strategy includes specific priority areas to ensure we foster
Open Positions Filled by Internal Candidates 30% 29% 31%
an inclusive community that works for our people, patients
and business. Employee E
Keyword: governance
I make a difference.”Our Approach to ESG Environmental Social Governance 60
2023 ESG Action Report
Our Global Strategy: EEDI Strategic Priorities We also strengthened the impact of inclusion by addressing
opportunities across the enterprise and functionally, with a
PowerHer: A Mentoring Program
Across the enterprise, our aligned global EEDI strategy
focus on belonging and well-being. Examples include:
for Women focusing on the following key areas in 2023: realizing a
diverse workforce; building people leader capabilities;
• Diversity Awareness Calendar
PowerHer is a mentoring program across our
strengthening community, well-being and belonging;
We continued our global Diversity Awareness Calendar,
Finance, Business Technology Solutions and
and scaling EEDI impact to enhance organizational
which celebrates and a
Keyword: governance
Lake County , IllinoisOur Approach to ESG Environmental Social Governance 61
2023 ESG Action Report
Cultivating Diversity and Inclusion:
Employee Resource Groups
Our ERGs’ Impact in 2023
Our Employee Resource Groups (ERGs) and Communities
strengthen our company culture and enrich our workplace by
Empowered and cultivated a Hispanic/Latinx
promoting awareness and fostering a diverse and inclusive
professional workforce of interns, employees and
environment. Open to all employees, they activate inclusion and
resilient leaders.
accelerate belonging to create an important sense of community
Increased chapter engagement and membership
and support for one another. AbbVie’s seven ERGs are company
at a local and global level. This was exemplified by
sponsored with executive leadership team support.
the celebration of PR
Keyword: governance
CommunitiesOur Approach to ESG Environmental Social Governance 62
2023 ESG Action Report
AbbVie Way Ambassadors of Culture
Key Performance Indicators: 2021 2022 2023
The AbbVie Way Ambassadors of Culture is a cross-
Equity, Equality, Diversity & Inclusion (EEDI)
functional team of 284 employee volunteers in 50 countries
who act as culture champions, catalysts and role models.
Total Employees 50,000 52,000 53,000
Serving as an extension of our Organizational Culture team,
they partner with local leaders and HR to develop and share
Women Globally 55% 56% 56%
tools and resources that help us celebrate and enhance our
culture. We recognize the importance of culture during our
Women on the Board of Directors1 - 27% 38%
Celebration of Culture, a week dedicated to reinforcing how
AbbVie’s culture makes us a
Keyword: governance
5 “Revenue-generating functions” means a position with AbbVie’s commercial organization.Our Approach to ESG Environmental Social Governance 63
2023 ESG Action Report
• Total Body Blueprint is our month-long, self-paced Workplace flexibility in where and when we work has always
Health and Well-Being
program that provides education and resources to reduce been at the core of AbbVie’s commitment to employee work-
At AbbVie, we partner with employees to help them be musculoskeletal injuries and issues. More than 5,000 life well-being. We understand that flexibility looks different
their best selves – at work and home. Because when we employees in 62 countries participated in 2023. for everyone, so we work together to support flexibility to
are at our best, AbbVie is at its best. We also recognize create a win-win for AbbVie employees, teams, patients and
• The website AbbVieVitali
Keyword: governance
More Races)Our Approach to ESG Environmental Social Governance 64
2023 ESG Action Report
We also reflect specific support with respect to therapeutic
Key Performance Indicators: Workplace Safety 2021 2022 2023
areas that are core to AbbVie. For example, in 2023, we
introduced eye exams during our biometric screenings
Recordable Incident Rate (Per 200,000 Hours Worked) 0.16 0.18 0.18¹
and flu shot event. In addition, we developed a migraine
management checklist that helps employees talk to their
Lost Time Injury Frequency Rate (Per 200,000 Hours Worked) 0.04 0.05 0.07¹
doctor, understand what a treatment plan might look like
and find ways to combat stress, a common trigger
Work-Related Employee and Contractor Fatalities 0 0 0
for migraines.
¹ The hours worked methodology was updated in 2023 to increase
Keyword: governance
safety associated with ISO 45001.Our Approach to ESG Environmental Social Governance 65
2023 ESG Action Report
Total Rewards
AbbVie is committed to providing a comprehensive and competitive total rewards package, covering In 2023, we extended our U.S. fertility benefits
to no longer require an infertility diagnosis and
every phase of an employee’s life and career with us. This helps attract, retain and engage the talent
introduced the AbbVie Inclusive Benefits Guide,
we need to drive our business growth. We offer our modern workforce a combination of robust and
which communicates what is available for our
meaningful benefits, compensation and well-being programs including, but not limited to:¹
LGBTQIA+² population, persons with disabilities,
military and veterans, and caregivers. We also
make professional help and guidance
Keyword: governance
² Lesbian, gay, bisexual, transgender, queer/questioning, intersex, asexual and other (such as non-binary and pansexual)Our Approach to ESG Environmental Social Governance 66
2023 ESG Action Report
Employee Support
The AbbVie Foundation is committed to assisting our
people and their families in times of need. The AbbVie
Employee Relief Program, which is funded and managed
by the Foundation, provides critical financial relief to
employees in the wake of disasters and personal hardship.
Additionally, the AbbVie Possibilities Scholarship Program,
funded by the AbbVie Foundation, alleviates the financial
strain of tuition costs so that the children of AbbVie
employees can achieve their full potential through post-
secondary education.
Possibilities Scholarship Employee Relief
Program 2023 Program 2023
100 $1.3
scholarships million
awarded to students in 23 in financial assistance
countries including U.S. provide
Keyword: governance
Lake County, IllinoisOur Approach to ESG Environmental Social Governance 67
2023 ESG Action Report
Community Engagement
Since our founding, we have led with purpose to make a lasting impact for patients, communities and society. We engage closely with
communities because we believe that is where meaningful change begins. We listen and learn from communities and our partners,
empowering them to determine the best solutions for their most pressing needs.
Our Approach Our philanthropic work is also supported through a range
of community grants, partnerships and employee giving
Our culture of giving is reflected in our philanthropic efforts,
and volunteering programs via the AbbVie Foundation. This
as well as the ways our employees around the world support
501(c)(3) nonprofit, which celebrated its 10th anniversary
Keyword: governance
North Chicago, IllinoisOur Approach to ESG Environmental Social Governance 68
2023 ESG Action Report
Our Corporate Giving
In 2023, AbbVie reached the end of an historic five-year, $350 million commitment to nine nonprofit organizations, creating long-term
impact across the United States and Puerto Rico. As part of our overall philanthropic effort, this signature corporate donation included:
$155 million $95 million $100 million
to organizations strengthening health care to education partners addressing systemic barriers to support immediate recovery efforts and
systems and promoting equitable access to and empowering students in under-resourced schools long-term resiliency after Puerto Rico was hit by
quality health care and communities two major hurricanes
Strengthening Health Care Systems Supporting Effective E
Keyword: governance
our partners to enhance and inform our philanthropic programs and continue driving impacts in the future.Our Approach to ESG Environmental Social Governance 69
2023 ESG Action Report
The AbbVie Foundation We collaborate with our partners to address the social
determinants that influence the health and well-being of
The AbbVie Foundation envisions a future where every
people in their communities, including access to health care,
individual has an equitable opportunity to realize their full
education, social and environmental conditions, financial
potential. We are committed to advancing health equity
stability and more. In selecting organizations to support
through innovative, community-centered partnerships
and collaborate with, we start by listening to and learning
and mobilizing our people to create a remarkable impact
from trusted partners and community stakeholders to
around the world.
ide
Keyword: governance
Chicago, IllinoisOur Approach to ESG Environmental Social Governance 70
2023 ESG Action Report
Advancing Racial Equity in • United Negro College Fund:
Enabled Black professionals to pursue careers in health
Health and Education
care, providing scholarships and support services to
more than 800 students through its Healthcare Diversity
In 2020, the AbbVie Foundation made a five-year, $50
Workforce Program
million commitment to advance health and education
equity in Black and other marginalized communities across • University of Chicago Medicine’s Urban Health Initiative:
the United States. Our six nonprofit partners have made Trained community health workers helped more than
significant strides to advance racial equity by reducing 27,000 residents in Chicago's south side navigate and
health disparities and p
Keyword: governance
Our Commitment to Advance Racial EquityOur Approach to ESG Environmental Social Governance 71
2023 ESG Action Report
Humanitarian and
Global Health Programmatic
Mariveles, Bataan, Philippines
Disaster Relief
Partners
In times of great need, the AbbVie Foundation provides The AbbVie Foundation supports long-standing global
support through a three-pronged approach that includes partners advancing health equity and strengthening
grants to nonprofits supporting recovery and resiliency of health care systems. These partners include:
communities, providing support to impacted employees
• Baylor College of Medicine International Pediatric
and donating essential products.
AIDS Initiative
• Turkey and Syria Provided comprehensive HIV care, treatment,
Following a massive earthquake in February 2023, the prevention, testing and psychosocia
Keyword: governance
Foundation Employee Relief Program.Our Approach to ESG Environmental Social Governance 72
2023 ESG Action Report
Employee Giving and Employee Volunteering employees in 56 countries and territories volunteered
more than 47,000 hours through 276 projects dedicated to
We support and empower employees to volunteer in a
Volunteering
strengthening local communities, enhancing educational
variety of ways, ranging from corporate-sponsored volunteer
programs and making a positive environmental impact.
activities to offering employees two paid days off a year for
AbbVie employees are essential to deepening the AbbVie
personal volunteering. Since 2013, AbbVie employees have
Across the world, our volunteers worked alongside our
Foundation’s collective impact, giving generously of their
volunteered nearly 300,000 hours in their local com
Keyword: governance
Ludwigshafen, GermanyOur Approach to ESG Environmental Social Governance 73
2023 ESG Action Report
Employee Giving
Through the AbbVie Foundation’s Employee
We support thousands of nonprofits through our Employee Giving and Matching program:
Giving Campaign, raising tens of millions of dollars each
year through employee donations matched by the AbbVie
$24.7
Foundation. 2023 was a record-breaking year, with more
than 22,000 employees in 55 countries and territories
raising more than $24.7 million (including the AbbVie’s million
Foundation’s match) for 13,720 charities and nonprofit raised for
organizations around the world. Through donations
13,720 $138
matched by the AbbVie Foundation, employees have raised
more than $138 million since the program’s inception.
charities million+
In addition, as part of our racia
Keyword: governance
4 These values include matching contributions from the AbbVie Foundation.Our Approach to ESG Environmental Social Governance 74
2023 ESG Action Report
Governance
Our success has come from a long tradition of strong 2023 Highlights
corporate governance and financial controls, a culture of
ethical behavior and an approach designed to minimize
business risk. Led by our Board of Directors, who play an
AbbVie further improved the Held our first
active and vital role in overseeing our strategic direction
and performance, we strive to hold our employees to
Diversity of its U.S. Ethics and
the highest expectations of business ethics. By acting
board of directors Compliance Week
with integrity, we aim to earn the trust of our patients,
business partners and other stakeholders.
in 2023 to further AbbVie’s commitment to
an ethical and compliant culture
Beyond abiding by ap
Keyword: governance
corporate governance framework, internal controls and
systems for risk management. We have also embedded
$1.03
human rights and ethical conduct considerations, as well
as supply chain and stakeholder engagement, into our billion+
decision-making across all levels of the organization.
spent working with over 2,500 small
and diverse businesses in the U.S. and
As we value transparency and accountability at AbbVie,
Puerto Rico
we continually take steps to enhance our non-financial
reporting every year.Our Approach to ESG Environmental Social Governance 75
2023 ESG Action Report
Corporate Governance
Our board is committed to strong corporate governance to enhance long-term shareholder value.
• Board independence:
Board Diversity
Twelve of our 13 directors are indep
Keyword: governance
Governance Committees. Since our inception, we
strengthens AbbVie’s business and the oversight of
have had a lead independent director with robust
the company.
responsibilities. Each board committee follows a charter
that outlines its purpose, authority and responsibilities.
Diversity, including diversity of race, ethnicity, gender,
age and geography, is an integral factor in identifying
• Self-evaluation:
prospective directors. In the process of nominating
To ensure continued and effective oversight, the board
an individual to serve as a member of the board, the
and its committees annually conduct detailed self-
Nominations and Governance Committee considers the
evaluations. The full board, led by the lead independent
existing board’s diversity and
Keyword: governance
our internal governance practices and disclosures.
San Francisco, CaliforniaOur Approach to ESG Environmental Social Governance 76
2023 ESG Action Report
Business Ethics
To make a positive, long-term impact for patients, we seek to earn and maintain their trust by acting with integrity in everything we do,
from strong corporate governance to the highest standards in quality, compliance, safety and performance.
Our Approach employees and businesses. The OEC is led by our Chief This includes monitoring compliance, providing awareness
Ethics and Compliance Officer (CECO), who is a member of and training for the program, revising policies and
We pride ourselves on our unwavering principles and our
of our Executive Leadership Team and regularly reports procedures, and
Keyword: governance
the compliance program.Our Approach to ESG Environmental Social Governance 77
2023 ESG Action Report
Ethical Conduct
OEC Internal Investigations Process
To make a positive, long-term impact for patients, we earn
and maintain their trust by acting with integrity, following all
relevant laws and industry codes, and leading with ethical
decision-making.
Code of Business Conduct
The foundation of our uncompromising integrity is our
Code of Business Conduct, on which all employees must
Corrective &
be trained and with which they agree to comply on an
Intake Investigation Conclusion Preventative
annual basis. Our Code of Business Conduct applies to all
Measures
employees globally and is available in 31 languages.
Complementing the Code of Business Conduct are Anyone can make a report Our OEC team includes We reach conc
Keyword: governance
anonymously, where permitted by law. good faith report.Our Approach to ESG Environmental Social Governance 78
2023 ESG Action Report
Global Health Care Compliance Policies Our risk assessment results and mitigation plans are In addition, we conduct live training programs, where
formally documented twice a year and are used to drive appropriate, using a situational business/compliance
Setting rules is not enough. That is why we emphasize
our ethics and compliance imperatives, goal setting and case study format on relevant scenarios derived from
values-based decision-making and provide clear policies
resource allocation. Cross-functional collaboration with recent investigations, audits, monitoring and other real-life
and procedures that help our employees understand how
business partners helps provide continuous insight into the situations, to re
Keyword: governance
appropriately tailor our risks. and comprehension.Our Approach to ESG Environmental Social Governance 79
2023 ESG Action Report
Key Performance Indicators: Ethics & Compliance¹ 2021 2022 2023
Driving Compliance and Ethical Culture
Outside of typical channels, we take opportunities to Assigned Employees Certifying to the AbbVie Code of Business Conduct 99% 99% 99%
reinforce an overall culture of ethics and compliance
across our organization. For example, in 2023, we Completion of Assigned Conflict of Interest Training by Full- and Part-time
- 99% 99%
held our first U.S. Ethics and Compliance Week, which Employees Globally2
was themed “Ethics and Compliance as a Strategic
Business Advantage.” With multiple informational Completion of Assigned Anti-Bribery and Anti-Corruption Training by Full-
- 99% 99%
sessions and interviews with senior lea
Keyword: governance
violence or threats of violence.Our Approach to ESG Environmental Social Governance 80
2023 ESG Action Report
Ethical Treatment The 3Rs: Refinement, Reduction, Replacement Public Policy
Our research philosophy centers on a commitment to the
of Animals In our public policy engagements, we are transparent and
internationally accepted principles of the 3Rs (refinement,
compliant with our Code of Business Conduct. We pursue
When developing innovative and impactful new medicines, reduction, replacement). This is demonstrated through our
and advocate for policies that benefit patients, with a focus
our methods reflect our strong commitment to the efforts to refine practices to minimize potential for pain and/
on improving access to medical advances and providing
responsible treatment of animals. Safety and efficacy or distress,
Keyword: governance
¹ Association for Assessment and Accreditation of Laboratory Animal CareOur Approach to ESG Environmental Social Governance 81
2023 ESG Action Report
Enterprise Risk Management
Cork, Ireland
Our Board of Directors regularly reviews enterprise risks, and our cross-functional leaders
provide regular reports on their areas of responsibility. Our Executive Crisis Management
Team anticipates and mitigates internal and external business risks. This team, led by our
Executive Vice President, Chief Operations Officer, and consisting of functional leaders
from across the enterprise, consider economic, environmental and other risks with potential
impacts to our patients, facilities, employees, partners and supply chains. With these inputs,
we establish risk management strategies and formal plans, which we routinely review and
adjust to improve effectiveness.
Risk Scenari
Keyword: governance
facilities. The surveys are designed to apply riskOur Approach to ESG Environmental Social Governance 82
2023 ESG Action Report
Data Privacy Guided by ethical principles and a commitment to human
rights, we continuously refine our Global Privacy Program, Lake County, Illinois
We consistently work toward meeting our worldwide
safeguarding personal data while upholding transparency
privacy obligations and ethical responsibilities concerning
and accountability standards.
the processing of personal data of all stakeholders. We
maintain a Global Privacy Program with policies and AbbVie Privacy Center
procedures aligned to relevant laws and regulations, as well
AbbVie’s Privacy Center is an innovative and interactive
as industry standards and best practices using the EU’s
centralized hub for our Privacy and Data Protection
General Data Protectio